As no significant effects on TP expression were observed following treatment with PAH SOCs in either model (Supplementary Tables 4, 5), a potential effect on TP expression following specific receptor engagement with NTP42:KVA4 is notable and may indicate a mechanism whereby TP antagonism may lead to beneficial RV effects. Here, CISH is linked to pulmonary arterial hypertension.